Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors

NCT00794131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancers (Solid Tumors)

Interventions

BIOLOGICAL: GL-ONC1

Sponsor

Genelux GmbH